Dr. Mark Dylewski, M.D.
What this data tells you about Dr. Dylewski
Dr. Mark Dylewski is a surgical oncology physician in Miami, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Dylewski performed 348 Medicare services across 345 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dylewski received a total of $368,788 from 24 pharmaceutical and/or device companies across 556 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgical oncology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dylewski is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Florida License Status
FL DOH · MQA| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 81351 | Clear | January 31, 2027 | — |
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| New patient office visit, complex (60-74 min) | 90 | $149 | $614 |
| Endoscopic removal of chest lymph nodes A surgical procedure to remove lymph nodes from the chest cavity using an endoscope, a thin tube with a camera inserted through small incisions. |
36 | $204 | $820 |
| Central venous port insertion A surgical procedure to place a small reservoir under the skin for long-term access to the bloodstream. The device is connected to a vein to allow for repeated medication administration or blood draws. |
30 | $236 | $1,164 |
| Fluoroscopic guidance for central vein access device Use of live X-ray imaging to guide the placement or removal of a central vein access device. |
30 | $16 | $70 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
23 | $75 | $565 |
| Lung exam with lobe removal via endoscope This procedure involves examining the lung and removing a lobe using an endoscope. It is performed to inspect the lung tissue and surgically remove a section of the lung. |
23 | $1,321 | $5,347 |
| Chest exam with lymph node biopsy via endoscope This procedure involves examining the chest using an endoscope and taking a tissue sample from a lymph node for testing. |
21 | $386 | $1,504 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $151 | $567 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
19 | $58 | $214 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
18 | $85 | $316 |
| Lung wedge biopsy and partial lung removal A surgical procedure involving the removal of a small wedge of lung tissue for examination, followed by the partial removal of the lung. |
14 | $155 | $595 |
| Adhesion of linings of lung using an endoscope | 13 | $559 | $2,390 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
11 | $104 | $605 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (62%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in surgical oncology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for surgical oncology physician in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Dylewski is a clinical cardiology specialist, with above-average Medicare volume (top 23% in FL), with speaking/promotional industry engagement in the top 1% of FL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Dylewski experienced with new patient office visit, complex (60-74 min)?
Does Dr. Dylewski receive payments from pharmaceutical companies?
How do Dr. Dylewski's costs compare to other surgical oncology physicians in Miami?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology